Dwarfism, Pituitary: all 171 studies
Page 2 of 2. Open to participants first (25), then studies with results posted, then the rest; newest registration first within each.
- Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD)CompletedNCT02507245
- Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)TerminatedNCT02413138Phase 2/3
- Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)TerminatedNCT02410356Phase 3
- Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)Status unknownNCT02380235Phase 4
- Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency ChildrenStatus unknownNCT02314676Phase 4
- PREPL in Health and DiseaseActive, not recruitingNCT02263781Not applicable
- Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)WithdrawnNCT02243852
- Bone Structure in Patients With Adult Onset Growth Hormone Deficiency Assessed Using High Resolution Peripheral Quantitative Computed TomographyCompletedNCT02218710
- A Follow-up Study to Examine the Presence of Anti-human Growth Hormone Antibodies Following a Study (FE 999905 CS07) of Zomacton in Children With Growth Hormone DeficiencyCompletedNCT02173821Phase 3
- Versartis Long-Term Safety Study of SomavaratanTerminatedNCT02068521Phase 2/3
- Assessing the Minimal Important Difference (MID) of the Treatment Related Impact Measure-Adult Growth Hormone Deficiency (TRIM-AGHD)CompletedNCT02005198
- A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone DeficiencyCompletedNCT01973244Phase 1
- GH and Cardiovascular Risk FactorsCompletedNCT01877512Phase 4
- Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency PatientsCompletedNCT01822340Phase 2
- Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone DeficiencyCompletedNCT01811576Phase 2
- Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone DeficiencyStatus unknownNCT01804413Not applicable
- Surveillance of Treatment of Children With Growth Hormone Deficiency With Zomacton®WithdrawnNCT01731028
- Versartis Trial in Children to Assess Long-Acting Growth HormoneCompletedNCT01718041Phase 1/2
- A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone DeficiencyCompletedNCT01706783Phase 1
- Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone DeficiencyTerminatedNCT01698944Phase 4
- French National Registry of Adults With Growth Hormone Deficiency Treated With SomatropinCompletedNCT01580605
- Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone DeficiencyCompletedNCT01563926Phase 3
- First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy SubjectsCompletedNCT01514500Phase 1
- Pharmacodynamics of CNP During Growth Hormone TreatmentCompletedNCT01504802
- Safety and Efficacy of Somatropin in Children With Growth Hormone DeficiencyCompletedNCT01502124Phase 3
- Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency ChildrenCompletedNCT01495468Phase 3
- Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTONCompletedNCT01365351
- VRS-317 in Adult Subjects With Growth Hormone DeficiencyCompletedNCT01359488Phase 1
- Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency ChildrenCompletedNCT01342146Phase 2
- Reference Values for Body Composition Parameters and IGF-I in the Adult NordiNet® International Outcome StudyCompletedNCT01120977
- Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone DeficiencyCompletedNCT01109017
- Diurnal Variation of Exogenous Peptides (GH Puls/Jurgita I)CompletedNCT01090778Phase 2
- Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone DeficiencyCompletedNCT01060488Phase 3
- An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)CompletedNCT01009905
- Cardiac Function and Morphology Evaluated by Magnetic Resonance Imaging in Growth Hormone Deficiency and AcromegalyCompletedNCT00970463
- Observational Prospective Study on Patients Treated With Norditropin®CompletedNCT00960128
- Growth Hormone and Glucose MetabolismCompletedNCT00929799Phase 4
- A Study of Zomacton in Children With Growth Hormone DeficiencyCompletedNCT00884000Phase 3
- Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone DeficiencyStatus unknownNCT00837863Phase 2
- Safety, Tolerability and PK/PD Study in Young Adult Patients With Childhood Onset Growth Hormone Deficiency (GHD).CompletedNCT00778518Phase 2
- Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone DeficiencyCompletedNCT00646815Not applicable
- A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head InjuryTerminatedNCT00638053Phase 4
- Treatment of Adults With Growth Hormone DeficiencyCompletedNCT00596037Phase 3
- Liquid Somatropin Formulation in Children With Growth Hormone DeficiencyCompletedNCT00567385Phase 4
- Growth Hormone Deficiency in Adults (GHDA)CompletedNCT00519558Phase 3
- Growth Hormone Deficiency in Chronic Heart Failure: an Observational StudyCompletedNCT00511927
- Safety Study of Syntropin (Human Growth Hormone) for the Treatment of Growth Hormone DeficiencyCompletedNCT00489294Phase 1
- Practicability and Acceptability of Stylomax® in ChildrenCompletedNCT00476385Phase 3
- Effect of Pegvisomant on GH/IGF-I Relationship in GHDTerminatedNCT00468624Not applicable
- Effect of 5 Years of GH Replacement on AtherosclerosisCompletedNCT00462475
- A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-DeficiencyCompletedNCT00455260Phase 1
- 304-C03/L3301n: Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone DeficiencyStatus unknownNCT00362063Not applicable
- A Single Dose Study to Evaluate the PK-PD Response and Safety of PHA-794428 in Children With Growth Hormone DeficiencyTerminatedNCT00314938Phase 2
- A Study To Evaluate The Dose Response And Safety Of PHA-794428 In Adults With Growth Hormone DeficiencyTerminatedNCT00308464Phase 2
- Treatment of Adults With Growth Hormone DeficiencyCompletedNCT00294619Phase 3
- Effect of Growth Hormone in Children With Growth Hormone DeficiencyCompletedNCT00262249Phase 3
- The IGFBP-3 Stimulation Test: A New Tool for the Diagnosis of Growth Hormone Deficiency in Children.CompletedNCT00235599
- Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral AssessmentsActive, not recruitingNCT00209235Not applicable
- Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone DeficiencyCompletedNCT00191360Phase 3
- Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)CompletedNCT00184743Phase 3
- Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)CompletedNCT00184730Phase 3
- Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone DeficiencyCompletedNCT00184678Phase 3
- Consequence of Lifetime Isolated Growth Hormone DeficiencyCompletedNCT00149708Not applicable
- IGF1 Generation TestCompletedNCT00145457Phase 4
- Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient WomenCompletedNCT00136032Not applicable
- Arimidex Multicenter Trial in Growth Hormone (GH) Deficient BoysCompletedNCT00133354Phase 2/3
- Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient ChildrenCompletedNCT00102817Phase 3
- Role of Nutrition and Hormones in Boys With Disordered GrowthCompletedNCT00102258Phase 2
- Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)CompletedNCT00097526
- National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) PatientsCompletedNCT00097513
- Randomized Study of Growth Hormone on Bone Mineral Density in Patients With Adult Onset Growth Hormone DeficiencyCompletedNCT00006394Not applicable